Results 211 to 220 of about 9,647,508 (315)
Dopaminergic influences on the P300 abnormality in Parkinson's disease
Young H. Sohn +3 more
openalex +2 more sources
LSMEM1, an evolutionarily conserved micropeptide with extreme hydrophobicity (aliphatic index═113) and dynamic amphiphilicity (GRAVY═0.017), features a strong α‐helical transmembrane anchor (residues 64‐86). Single‐cell analysis reveals its critical role in renal lipid homeostasis.
Peimin Liu +11 more
wiley +1 more source
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
C. Paisán-Ruiz +20 more
semanticscholar +1 more source
Pleiotropy and the Increasing Complexity of Parkinson's Disease Genetics. [PDF]
Kim J, Shulman JM.
europepmc +1 more source
Three food‐grade nanomaterials induce dysregulated RyR‐Ca2+ signaling through epigenetic modifications. This dysregulation impairs the autophagic clearance process, ultimately leading to abnormal Aβ deposition and increase phosphorylated tau levels.
Jiaxin Shang +7 more
wiley +1 more source
Exploring Ayurveda's Potential in Parkinson's Disease: A Comprehensive Narrative. [PDF]
Chikkanna U +7 more
europepmc +1 more source
This study examines major depressive disorder with atypical features and psychotic symptoms through a multi‐omics precision medicine approach. By integrating clinical assessments, WBC scRNA‐seq, plasma proteomics, and brain organoid models, it uncovers immune dysregulation, synaptic protein alterations, and stress‐sensitive neuronal changes.
Insook Ahn +5 more
wiley +1 more source
Dermal Alpha-Synuclein Aggregation in Seed Amplification Assays for Parkinson's Disease Subtype Differentiation. [PDF]
Vieregge M +6 more
europepmc +1 more source

